Julia Stomper

6PUBLICATIONS
18CO-AUTHORS
Haematological tumoursHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 07, 2025
Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial.

Inga Hund, Maria Elena Hess, Geoffroy Andrieux

|Aug 22, 2022
The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.

Ruth Meier, Gabriele Greve, Dennis Zimmer

|Mar 23, 2022
Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes.

Julia Stomper, Paulina Richter-Pechanska, Dietmar Pfeifer

|May 07, 2021
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies.

Julia Stomper, John Charles Rotondo, Gabriele Greve

|Nov 18, 2020
Decitabine Induces Gene Derepression on Monosomic Chromosomes: <i>In Vitro</i> and <i>In Vivo</i> Effects in Adverse-Risk Cytogenetics AML.

Gabriele Greve, Julia Schüler, Björn A Grüning

|Mar 25, 2020
Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine.

Annette M May, Julia Stomper, Tina E Joeckel

Pageof 1

Frequent Collaborators

4 joint publications

Michael Lübbert

2 joint publications

Christoph Plass

1 joint publications

Annette M May

1 joint publications

Julia Schüler